SecBot SecBot
Insider Buy ·Filed Aug 3, 2026

NXTC

NextCure, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed2mo ago SEC0001940272-26-000013
Insider cluster: 1 insiders, $1.4M total
Actionable Insight ▲ Bullish

The insider's large position buildup is a strong bullish signal on a standalone basis, but given the micro-cap's poor historical follow-through on similar reports, traders should seek additional catalysts (e.g., pipeline updates or financing clarity) before committing capital. Monitor for further SEC filings or operational news.

DirectionBullish
Confidencemedium
Horizonweeks
Latest settled — T+20d ⚠ clustered
NXTC ▲ +17.65% at T+20d
LONG call ✓ call won +17.65% · α vs SPY +18.89% · entry $5.78 → $6.80
Next anchor: T+60d due 2h ago
Latest observation: T+57 +128.99% FF3 residual α
Entry = T+0 close
Aug 3, 2026
via day close
T+1d
-9.17%
call -9.17% · α -8.97%
$5.25
settled 3mo ago
T+5d
+16.44%
call +16.44% · α +16.54%
$6.73
settled 3mo ago
T+20d
+17.65%
call +17.65% · α +18.89%
$6.80
settled 8w ago
T+60d
Pending
due 2h ago

Price Chart

Loading chart...

Executive Summary

ADAR1 Capital Management, LLC, a 10% owner, purchased approximately $1.43 million of NXTC shares over July 23-30, 2026, representing roughly 9.5% of the company's $15 million market cap.

Key Financial Metrics

Direction
buying
Total Value
$1.4M
Insiders
1

Key Facts

  • ADAR1 Capital Management, a 10% owner, bought a total of ~$1.43M in NXTC shares across multiple transactions from July 23-30.
  • The purchase represents approximately 9.5% of NXTC's market cap, a highly material insider cluster buy.
  • All transactions were open-market purchases; no 10b5-1 plan indicated.

Financial Impact

Insider purchase of $1.43M, ~9.5% of $15M market cap, significantly concentrates ownership.

ownership concentration

Risk Factors

  • Micro-cap liquidity and volatility could amplify losses; $15M market cap is highly speculative.
  • The company may need additional capital, which could dilute existing shareholders.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0001940272-26-000013
17 reports for NXTC
Performance horizon
75% Hit rate @ T+60 3 of 4 directional calls Went positive at some point 5 of 5 best @ T+60▲ +74.85%Jun 1, 2026
Filters
Rows
Reports for NXTC — sortable, filterable
TypeNow
Oct 20, 2026
7d ago
SC 13G
NEUTRAL ★ 4/10
$5.44awaiting T+60—$5.30 (−2.48%)
Sep 25, 2026
4w ago
425
NEUTRAL ★ 5/10
$5.08awaiting T+60—$5.30 (+4.43%)
Sep 25, 2026
4w ago
8-K
NEUTRAL ★ 5/10
$5.08awaiting T+60—$5.30 (+4.43%)
Aug 10, 2026
11w ago
425
BEARISH ★ 7/10
$6.73awaiting T+60—$5.30 (+21.17%)
Aug 4, 2026
12w ago
425
NEUTRAL ★ 5/10
$5.78awaiting T+60—$5.30 (−8.22%)
Aug 3, 2026
12w ago
Insider Buy
BULLISH ★ 6/10
$5.78awaiting T+60—$5.30 (−8.22%)
Jul 29, 2026
12w ago
Insider Buy
NEUTRAL ★ 4/10
$5.03 $4.98▼ −0.99%▼ −3.46%$5.30 (+5.47%)
Jul 14, 2026
15w ago
425 / 8-K
BULLISH ★ 7/10
$6.58 $6.56▼ −0.30%▼ −3.68%$5.30 (−19.38%)
Jul 14, 2026
15w ago
8-K
BEARISH ★ 7/10
$6.58 $6.56▲ +0.30%▲ +3.68%$5.30 (+19.38%)
Jun 1, 2026
21w ago
8-K
BULLISH ★ 6/10
$3.38 $5.91▲ +74.85%▲ +73.62%$5.30 (+56.95%)
Showing 10 of 17

US Market Status

Market Open — Closes in 6h 18m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 3, 2026